Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26809-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- BCLAF1 antibody
- Antibody type
- Polyclonal
- Description
- BCLAF1 antibody (Cat. #26809-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references LncRNA AC021683.2 promotes chemotherapy resistance in acute myeloid leukemia.
cDTL contributes to breast cancer progression through regulating redox homeostasis via affecting the function of system xc().
Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma.
BCLAF1 is Expressed as a Potential Anti-oncogene in Bile Duct Cancer.
The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer.
SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing.
Hsp90 Inhibitor STA9090 induced VPS35 related extracellular vesicle release and metastasis in hepatocellular carcinoma.
The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response.
LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Li L, An XN, Ruan YT, Liang X, Hao JL, Gao GX, Bi JF, Gao YR, Lu X, Tang HL, Gao P, Dong XM
iScience 2025 Sep 19;28(9):113439
iScience 2025 Sep 19;28(9):113439
cDTL contributes to breast cancer progression through regulating redox homeostasis via affecting the function of system xc().
Wang S, Liu L, Li X, Li Q, Wang Y, Feng X
Biochemical and biophysical research communications 2025 Jan;744:151196
Biochemical and biophysical research communications 2025 Jan;744:151196
Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma.
Yan H, Wu X, Li H, Yu Z, Jin X
Biochemical genetics 2025 Apr;63(2):1479-1508
Biochemical genetics 2025 Apr;63(2):1479-1508
BCLAF1 is Expressed as a Potential Anti-oncogene in Bile Duct Cancer.
Zhou Y, Ran X, Han M
Biochemical genetics 2024 Oct;62(5):3681-3694
Biochemical genetics 2024 Oct;62(5):3681-3694
The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer.
Ge Y, Zhang Y, Yang S, Liu T, Zhang T, Feng Y, Wang C, Liang G
Journal of oncology 2023;2023:9822995
Journal of oncology 2023;2023:9822995
SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing.
Liu W, Lu X, Zhao ZH, Su R, Li QL, Xue Y, Gao Z, Sun SS, Lei WL, Li L, An G, Liu H, Han Z, Ouyang YC, Hou Y, Wang ZB, Sun QY, Liu J
eLife 2022 Nov 10;11
eLife 2022 Nov 10;11
Hsp90 Inhibitor STA9090 induced VPS35 related extracellular vesicle release and metastasis in hepatocellular carcinoma.
Tan W, Zhang J, Liu L, Liang M, Li J, Deng Z, Zheng Z, Deng Y, Liu C, Li Y, Xie G, Zhang J, Zou F, Chen X
Translational oncology 2022 Dec;26:101502
Translational oncology 2022 Dec;26:101502
The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response.
Zong X, Xiao X, Shen B, Jiang Q, Wang H, Lu Z, Wang F, Jin M, Min J, Wang F, Wang Y
Nucleic acids research 2021 Jun 4;49(10):5537-5552
Nucleic acids research 2021 Jun 4;49(10):5537-5552
LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M, Zhang R, Lu L, Du J, Chen C, Ding K, Wei X, Zhang G, Huang Y, Hou J
Aging 2020 Nov 16;12(21):22291-22312
Aging 2020 Nov 16;12(21):22291-22312
No comments: Submit comment
No validations: Submit validation data